Skip to content
Teleflex Inc icon

Teleflex Inc

TFXStocksMedical SpecialtiesUnited StatesNYSEUSD

Price

$125.58

Today

+0.5%

YTD

+3.1%

About

Teleflex Incorporated is a healthcare company that designs, makes, and supplies single-use medical devices for diagnostic and therapeutic procedures. These products are used in critical care and surgical applications. Incorporated in 1943, Teleflex operates internationally throughout the United States, Latin America, the Asia Pacific, Europe, Africa, and the Middle East. The company has its headquarters in Wayne, Pennsylvania. Teleflex distributes its devices and other products under the Arrow, Deknatel, Hudson RCI, LMA, Pilling. Rüsch, UroLift, and Weck brands. The company’s portfolio covers solutions in the areas of vascular and interventional access, surgical procedures, anaesthesia, cardiac care, urology, emergency medicine, and respiratory care. The Arrow brand focuses on catheter and tip positioning systems, intraosseous access for intravenous therapies, blood pressure measuring, and obtaining blood samples through single puncture sites. Teleflex’s interventional products include coronary catheters, structural heart therapies, and peripheral and cardiac assist therapies. Teleflex applications are used by cardiologists, radiologists, anaesthesiologists, and vascular surgeons in their respective fields. In urology, the UroLift System provides invasive technology to treat lower urinary tract symptoms. Additionally, Teleflex provides services to healthcare providers, medical device manufacturers, and home care providers. The company trades on the NYSE using the TFX stock ticker. Track the TFX price value with your eToro watchlist.

Price chart
Closing price history for TFX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-5.38
P/S (TTM)2.10
P/B (TTM)1.83
Market cap$5.31B
Cap tierMid-cap
Industry avg P/E17.61

Profitability

Gross margin60.89%
EBIT margin11.02%
Net margin7.32%
ROE-10.51%
ROA-5.30%

Earnings & Revenue

Revenue (TTM)$2.60B
Revenue growth (1Y)-14.5%
EPS (TTM)-$23.29
Free cash flow$339.77M
Total debt$2.87B

Dividends & Risk

Dividend rate$1.36
Dividend yield1.09%
Ex-date22 May '26
Beta (5Y)0.78
Employees15,500
Next earnings29 Oct '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.